FIŞA DE VERIFICARE

a îndeplinirii standardelor minimale în vederea obţinerii atestatului de abilitare

în cadrul I.O.S.U.D. Universitatea Titu Maiorescu, Bucureşti

Domeniile de doctorat: Medicină

I. Date despre candidat

Nume: Sîrbu

Prenume: Carmen Adella

1. Doctor în ştiinţe

X□ DA □ NU

„Hidatidoza cerebrala”,

Conducător ştiinţific Prof.dr Simona Radulescu (2004), UMF Carol Davila

Bucuresti, seria D/0003025, nr 1725/09.XII.2004

Ordinul de confirmare: 4450 din 2 august 2004

2. Medic/ medic dentist/farmacist primar în specialitatea postului (la disciplinele cu

corespondent în reţeaua Ministerului Sănătăţii)

X□ DA □ NU

Ordinul de confirmare: 1067/2004 pe baza examenului susținut în sesiunea iunie

2004 și promovat cu media generală 9,77 (medic primar neurolog)

II. Date numerice privind îndeplinirea standardelor minimale naţionale, conform anexelor nr.

20 şi 23 ale Ordinului Ministrului Educaţiei Naţionale şi Cercetării Ştiinţifice nr.

6129/20.12.2016

1. Articole publicate în reviste cotate ISI în calitate de autor principal

Criteriul Standard minim Realizat

Număr articole publicate în

reviste cotate ISI în calitate

de autor principal

10 12

Criteriu îndeplinit:

X□ DA □ NU

Lista articolelor ISI publicate în calitate de autor principal: autori, titlu articol, revistă, an,

volum, pagini, factor de impact:

AP1. Sirbu, C.A.; Dantes, E.; Plesa, C.F.; Docu Axelerad, A.; Ghinescu, M.C. Active

Pulmonary Tuberculosis Triggered by Interferon Beta-1b Therapy of Multiple Sclerosis: Four

Case Reports and a Literature Review (Review). Medicina-Lithuania, 2020; 56 (202):1-7.

doi.org/10.3390/medicina56040202, FI= 1,467.

AP2. Sirbu CA, Mezei RM, Falup‑Pecurariu C, Bratu OG, Sirbu AM, Ghinescu MC, Ionita

Radu F. Autonomic dysfunctions in multiple sclerosis: Challenges of clinical practice

(Review). Exp. Ther. Med 20: 196, 2020, Published online on: 14 octombrie 2020,

https://doi.org/10.3892/etm.2020.9326, IF=1,785

AP3. Sîrbu OM, Chirteş AV, Mitricã M, Sîrbu CA. Spinal Intramedullary Epidermoid Cyst:

Case Report and Updated Literature Review. World Neurosurg. 2020;139:39‐50.

DOI: https://doi.org/10.1016/j.wneu.2020.03.207, FI=1,723.

AP4. Sirbu CA, Florea AA, Ghinescu MC, Docu‑Axelerad A, Sirbu AM, Bratu OG, Ionita

Radu F. Vaccination in multiple sclerosis ‑ Challenging practices (Review). Exp. Ther. Med

20: 217, 2020. Published online on: October 15, 2020 https://doi.org/10.3892/etm.2020.9347,

IF=1,785

AP5. Sirbu CA, Budisteanu M, Falup-Pecurariu C. Monoclonal antibodies - a revolutionary

therapy in multiple sclerosis. Neurol Neurochir Pol. 2020;54(1):21‐27.

DOI: 10.5603/PJNNS.a2020.0008 , IF=1,006.

AP6. Sirbu CA, Plesa FC, Ghinescu MC, Caloianu I, Ionita-Radu F, Persistence on interferon

beta-1b in multiple sclerosis: 19-year of follow-up, Farmacia, 68(4): 7752-756, 2020,

https://doi.org/10.31925/farmacia.2020.4.23, IF=1,527.

AP7. Budisteanu M, Andrei E, Linca F, Hulea DS, Velicu AC, Mihailescu I, Riga S, Arghir

A, Papuc SM, Sirbu CA, Mitrica M, Docu‑Axelerad A, Ghinescu MC, Dobrescu I, Rad F.

Predictive factors in early onset schizophrenia. Exp. Ther. Med 20: 210, 2020. Published

online on: October 14, 2020 https://doi.org/10.3892/etm.2020.9340, IF=1,785 (corresponding

author).

AP8. Sîrbu CA, Drăgoi CM, Nicolae AC, Pleșa CF, History of interferon treatments in

multiple sclerosis – 60 years of progress, Farmacia, 2017, Vol. 65, 1, 14-18,

http://farmaciajournal.com/issue-articles/history-of-interferon-treatments-in-multiple-

sclerosis-60-years-of-progress/ IF=1,507

AP9. Nicolae AC, Arsene AL, Vuță V, Popa DE, Sirbu CA, Burcea-Dragomiroiu IB,

Dumitrescu GTA, Velescu BS, Gofiță E, Drăgoi CM (All authors have equal contribution) - In

vitro P-gp expression after administration of CNS active drugs, Farmacia, nr.6, 2016,vol 64,

ISSN: 2065-0019 http://www.revistafarmacia.ro/201606/issue62016art7.html, IF=1.348

AP10. Sirbu CA, Furdu-Lungut E, Plesa CF, Nicolae AC, Dragoi CM, Pharmacological

treatment of relapsing remitting multiple sclerosis-where we are throw evidence based

medicine?–review , Farmacia nr 5 2016,vol 64, 5, pag 651-655, ISSN: 2065-0019

http://www.revistafarmacia.ro/201605/issue52016art1.html IF=1.348

AP11. Sirbu CA, Sirbu OM, Constantin C, Sandu AM, Neuroimunotoxicity Of Aluminum,

Farmacia, 2015 nr.1 Vol. 63, 1, pag. 8-10, ISSN: 2065-0019

http://www.revistafarmacia.ro/201501/issue12015art2.html, IF=1.162

AP12. Sîrbu C. Arthur Kreindler (1900–1988). Journal of Neurology, 253, 965–966 (2006).

https://doi.org/10.1007/s00415-006-0939-8, IF=3,853

2. Articole publicate în reviste cotate ISI în calitate de coautor

Criteriul Standard minim Realizat

Număr articole publicate în

reviste cotate ISI în calitate

de coautor

5 9

Criteriu îndeplinit:

X □ DA □ NU

Lista articolelor ISI publicate în calitate de coautor: autori, titlu articol, revistă, an, volum,

pagini, factor de impact

CA1. Falup-Pecurariu C, Diaconu Ș, Falup-Pecurariu O, Ciopleiaș B, Sîrbu CA. Acute

reversible parkinsonism post-influenza infection. Acta Neurol Belg. 120, 723–724, 2020.

https://doi.org/10.1007/s13760-019-01215-2 , IF=1,612

CA2. Sirbu AM, Sirbu CA, Eftimie L, Soare AM, Ghinescu MC, Ionita-Radu F. Multiple

sclerosis, human herpesvirus 4 and thyroid collision tumor: A case report. Exp Ther Med.

2020 Oct;20(4):3458-3461. doi: 10.3892/etm.2020.8975. Epub 2020 Jul 7. PMID: 32905114;

PMCID: PMC7465335, IF=1,785

CA3. Strand EB, Nacul L, Mengshoel AM, Helland IB, Grabowski P, Krumina A, Alegre-

Martin J, Efrim-Budisteanu M, Sekulic S, Pheby D, Sakkas GK, Sirbu CA, Authier FJ;

European Network on ME/CFS (EUROMENE). Myalgic encephalomyelitis/chronic fatigue

Syndrome (ME/CFS): Investigating care practices pointed out to disparities in diagnosis and

treatment across European Union. PLoS One. 2019;14(12):e0225995. Published 2019 Dec 5.

https://doi.org/10.1371/journal.pone.0225995 IF=2,776

CA4. Zhou Y, Claflin SB, Stankovich J, van der Mei I, Simpson S Jr, Roxburgh RH, Kalincik

T, Blizzard L, Lugaresi A, Alroughani R, Sajedi SA, Butzkueven H, Pucci E, Spitaleri D,

Granella F, Cristiano E, Yamout B, Hughes S, Gouider R, Sánchez Menoyo JL, Olascoaga J,

McGuigan C, Shaw C, Kermode AG, Kasa K, Al-Harbi T, Altintas A, Laureys G, Fragoso Y,

Hardy TA, Csepany T, Sirbu CA, Decoo D, Sas A, Alvarez-Cermeño JC, Kotkata K, Millán-

Pascual J, Taylor BV. Redefining the Multiple Sclerosis Severity Score (MSSS):Redefining

the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype. Mult

Scler. 2019 Oct 31:1352458519881994. https://doi.org/10.1177/1352458519881994 Online ahead

of print.PMID: 31668127 , IF= 5.649

CA5. Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C,

Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA,

Overell J, Piehl F, Rasmussen PV, Sá MJ, Sîrbu CA, Skromne E, Torkildsen Ø, van Pesch V,

Vollmer T, Zakaria M, Ziemssen T, Giovannoni G. International consensus on quality

standards for brain health-focused care in multiple sclerosis. Mult Scler. 2019 Nov;

25(13):1809-1818. https://doi.org/10.1177/1352458518809326 Epub 2018 Nov

1.PMID: 30381987 , IF= 5.649

CA6. Kalincik T, Kuhle J, Pucci E, Rojas JI, Tsolaki M, Sirbu CA, Slee M, Butzkueven H;

MSBase Scientific Leadership Group and MSBase Study Group. Data quality evaluation for

observational multiple sclerosis registries. Mult Scler. 2017 Apr;23(5):647-655.

DOI: 10.1177/1352458516662728 Epub 2016 Aug 5.PMID: 27481209, IF = 4,840

CA7. Kalincik T, Buzzard K, Jokubaitis V, Trojano M, Duquette P, Izquierdo G, Girard M,

Lugaresi A, Grammond P, Grand'Maison F, Oreja-Guevara C, Boz C, Hupperts R, Petersen T,

Giuliani G, Iuliano G, Lechner-Scott J, Barnett M, Bergamaschi R, Van Pesch V, Amato MP,

van Munster E, Fernandez-Bolanos R, Verheul F, Fiol M, Cristiano E, Slee M, Rio ME,

Spitaleri D, Alroughani R, Gray O, Saladino ML, Flechter S, Herbert J, Cabrera-Gomez JA,

Vella N, Paine M, Shaw C, Moore F, Vucic S, Savino A, Singhal B, Petkovska-Boskova T,

Parratt J, Sirbu CA, Rozsa C, Liew D, Butzkueven H; MSBase Study Group. Risk of relapse

phenotype recurrence in multiple sclerosis.

Mult Scler. 2014 Oct;20(11):1511-22. Epub 2014 Apr 28.PMID: 24777276

DOI: 10.1177/1352458514528762, IF=4,822

CA8. Kalincik T, Vivek V, Jokubaitis V, Lechner-Scott J, Trojano M, Izquierdo G, Lugaresi

A, Grand'maison F, Hupperts R, Oreja-Guevara C, Bergamaschi R, Iuliano G, Alroughani R,

Van Pesch V, Amato MP, Slee M, Verheul F, Fernandez-Bolanos R, Fiol M, Spitaleri DL,

Cristiano E, Gray O, Cabrera-Gomez JA, Shaygannejad V, Herbert J, Vucic S, Needham M,

Petkovska-Boskova T, Sirbu CA, Duquette P, Girard M, Grammond P, Boz C, Giuliani G, Rio

ME, Barnett M, Flechter S, Moore F, Singhal B, Bacile EA, Saladino ML, Shaw C, Skromne

E, Poehlau D, Vella N, Spelman T, Liew D, Kilpatrick TJ, Butzkueven H; MSBase Study

Group. Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.

Brain. 2013 Dec;136(Pt 12):3609-17. https://doi.org/10.1093/brain/awt281 Epub 2013 Oct

18.PMID: 24142147, IF=10,226

CA9. Meyniel C, Spelman T, Jokubaitis VG, Trojano M, Izquierdo G, Grand'Maison F, Oreja-

Guevara C, Boz C, Lugaresi A, Girard M, Grammond P, Iuliano G, Fiol M, Cabrera-Gomez

JA, Fernandez-Bolanos R, Giuliani G, Lechner-Scott J, Cristiano E, Herbert J, Petkovska-

Boskova T, Bergamaschi R, van Pesch V, Moore F, Vella N, Slee M, Santiago V, Barnett M,

Havrdova E, Young C, Sirbu CA, Tanner M, Rutherford M, Butzkueven H; MSBasis Study

Group. Country, sex, EDSS change and therapy choice independently predict treatment

discontinuation in multiple sclerosis and clinically isolated syndrome. PLoS One.

2012;7(6):e38661. DOI: 10.1371/journal.pone.0038661 Epub 2012 Jun 29.PMID: 22768046 ,

IF= 3.730

3. Factorul cumulat de impact pentru articolele publicate ca autor principal în reviste

cotate ISI (FCIAP)

Criteriul Standard minim Realizat

(ISI) Factor cumulat de

impact autor principal

10 16,913

Criteriu îndeplinit:

X□ DA □ NU

4. Indexul Hirsch

Criteriul Standard minim Realizat

Index Hirsch 6 7

Criteriu îndeplinit:

X□ DA □ NU

Confirm prin prezenta că datele menționate mai sus sunt reale și se referă la propria mea

activitate profesională și științifică

Articole ISI unde sunt coautor:

Data Semnătura candidatului

23.10.2020 Conf.univ.dr.

Carmen Adella Sirbu